跳转至内容
Merck
CN

880128C

Avanti

DSPE-PEG(2000)胺

Avanti Research™ - A Croda Brand

别名:

1,2-二硬脂酰-sn-丙三基-3-磷酸乙醇胺-N-[氨基（聚乙二醇）-2000 (铵盐)

登录 查看组织和合同定价。

选择尺寸

关于此项目

化学文摘社编号:
474922-26-4
UNSPSC Code:
12352211
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

DSPE-PEG(2000)胺, Avanti Research™ - A Croda Brand 880128C

SMILES string

[H][C@@](COP([O-])(OCCNC(OCCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO/C=C\N)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.

assay

>99% (TLC)

form

liquid

packaging

pkg of 1 × 1 mL (880128C-10mg), pkg of 1 × 2.5 mL (880128C-25mg), pkg of 1 × 20 mL (880128C-500mg), pkg of 1 × 4 mL (880128C-100mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 880128C

concentration

10 mg/mL (880128C-10mg), 10 mg/mL (880128C-25mg), 25 mg/mL (880128C-100mg), 25 mg/mL (880128C-500mg)

shipped in

dry ice

storage temp.

−20°C

正在寻找类似产品? 访问 产品对比指南

General description

二硬脂酰磷脂酰乙酰胺-聚乙二醇(2000)-氨基/DSPE-PEG(2000)胺是一种偶联聚乙二醇(PEG)的功能化脂质。

Application

DSPE-PEG(2000)胺已用于：
  • 制备胺功能化囊泡
  • 制备小单室囊泡
  • 制备脂质体

Packaging

30 mL棕色窄口螺旋盖玻璃瓶（880128C-500mg）
5 mL透明玻璃密封安瓿瓶(880128C-100mg)
5 mL透明玻璃密封安瓿瓶(880128C-10mg)
5 mL透明玻璃密封安瓿瓶(880128C-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

target_organs

Central nervous system, Liver,Kidney

存储类别

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

flash_point_f

does not flash

flash_point_c

does not flash

法规信息

易制毒化学品（2类）
危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Olga B Garbuzenko et al.
Theranostics, 9(26), 8362-8376 (2019-11-23)
Non-Small Cell Lung Carcinoma (NSCLC), is the most common type of lung cancer (more than 80% of all cases). Small molecule Tyrosine Kinase (TK) Inhibitors acting on the Epidermal Growth Factor Receptors (EGFRs) are standard therapies for patients with NSCLC
Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency
Jayanna PK, et al.
Nanomedicine: Nanotechnology, Biology, and Medicine, 6(4), 538-546 (2010)
Stabilization and immobilization of aquaporin reconstituted lipid vesicles for water purification
Sun G, et al.
Colloids and Surfaces. B, Biointerfaces, 102, 466-471 (2013)
Venugopal Vangala et al.
Molecular pharmaceutics, 17(6), 1859-1874 (2020-04-29)
Glioblastoma multiforme (GBM) is one of the most aggressive tumors with a median survival of only 15 months. Effective therapeutics need to overcome the formidable challenge of crossing the blood-brain barrier (BBB). Receptors and transporters overexpressed on BCECs are being
Anujan Ramesh et al.
Biomaterials, 227, 119559-119559 (2019-11-02)
Among the numerous immune interactions, or lack-thereof, that occur during cancer progression, tumor-associated macrophages (TAMs) - cancer cell interactions have been shown to play an important role in modulating the tumor-microenvironment to an immune suppressive mode, promoting accelerated tumor growth
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持